The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition

Journal of Psychopharmacology (2011) - Comment
pubmed: 20305042 doi: 10.1177/0269881110364272 issn: 1461-7285 issn: 0269-8811

Neil E Paterson, Fuat Balci, Una Campbell, Berend E Olivier, Taleen Hanania